Capnography Equipment Market by Product (Equipment: Multiparameter, Standalone, Handheld; Software, Accessory), Technology (Microstream), Application (Cardiac care, Trauma, Emergency, Respiratory), End User (Hospitals, ASC, Home) - Global Forecasts to 2029
The global Capnography Equipment market is projected to reach USD 458.8 million by 2029 from USD 374.2 million in 2024, growing at a CAGR of 4.2% during the forecast period. Growth factors include the high incidence of chronic respiratory diseases such as asthma, COPD, and sleep apnea are significantly driving the market for capnography equipment. An upsurge in home healthcare would require non-invasive monitoring solutions, thus boost the growth of this market. Improvements in technology especially about miniaturization, reduced profile, and wireless connectivity would ensure that capnography equipment is portable and user-friendly.
“Capnography accessories & disposables to register largest market share in 2022-2029.”
The largest share in capnography equipment consists of capnography accessories & disposables. Capnography accessories and disposables are also some of the necessary parts of the proper working of capnography equipment. These include disposable sampling lines, filters, and connectors, which are very necessary to maintain hygiene levels and prevent cross-contamination. Calibration gases are also needed to ensure the accuracy of measurements of capnography. Other devices would include power cords, wall mounts, and carrying cases that increase the convenience and portability of capnography devices.
“Hospitals segment held the largest share of capnography equipment market in 2023, by End-user.”
Based on the end-user, the capnography equipment market is segmented into hospitals. ambulatory surgery centers & home care and other end users. In the year 2023, the global capnography equipment market was dominated by hospitals. The use of capnography equipment is extremely prevalent in critical care areas, such as ICUs, operating rooms, emergency departments, and respiratory care units of hospitals. Such hospitals form the biggest market in the capnography equipment market because of this widespread usage. The growth of surgeries, critical care procedures, and respiratory illnesses has further led to a growing demand for capnography devices. In addition, the increased practice of monitoring patients for early respiratory complications detection along with the development of acute care has worked in favor of the integration of capnography in the clinical settings of hospitals.
'Asia Pacific to register highest growth rate in the market during the forecast period.'
The Asia-Pacific region is projected to exhibit the highest CAGR in the capnography equipment market. This growth is primarily driven by factors such as increasing healthcare expenditure, rising prevalence of respiratory diseases, growing geriatric population, and increasing awareness about the benefits of early detection and treatment of respiratory disorders. Additionally, the expanding healthcare infrastructure and increasing adoption of advanced medical technologies in countries like India and China are further contributing to the growth of the capnography equipment market in this region.
A number of drivers were responsible for the upswing, including:
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
Capnography equipment market is segmented by product, technology, application, end-user, and region. Factors determining market growth are driving forces, restrains, opportunities, and challenges, as well as those offering opportunities and challenges for stakeholders. Further examining the competitive landscape among the top players, the report does this. In doing so, it further segments the market into micro-markets for analyzing growth trends, prospects, and contribution to the overall market. It outlines the future revenue growth across the different market segments in five of the major regions.
Key Benefits of Buying the Report:
The report would be useful for new market entrants in the capnography equipment market as it gives detailed information about the market. This helps to get a good understanding of any investment opportunities. The report provides in-depth insight into key and smaller players which helps in doing strong risk assessment for investment decisions. The report segments the market precisely by both end-users and by regions to gain focused insights in specific market segments. Furthermore, it outlines the critical trends, challenges, growth drivers, and opportunities to facilitate strategic decision-making through well-rounded analysis.
The report provides the insights on the following pointers:
Analysis of the key drivers, restraints, opportunities, and challenges influencing the rise of the capnography equipment market The majority of the capnography equipment market is driven by the increase in chronic respiratory diseases such as asthma, COPD, and sleep apnea. There is an increasing demand for non-invasive monitoring solutions, especially in home care environments. Advancements in technology also involve miniaturization and wireless connectivity that enable smaller and user-friendly size capnography devices to be utilized.
Product Development/Innovation: The report showcases emerging technologies in the domain, ongoing R&D activities, and recent product and service launches in the market for capnography equipment.
Market Development: It has elaborated about the new product development and unexplored markets, latest developments, and investment in the capnography equipment market.
Market Diversification: Detailed insight into new product launches, unexplored markets, recent developments, and investments made in the capnography equipment market.
Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as Becton, Dickinson and company (US), Medtronic (US), Koninklijke Philips N.V.(Netherlands), GE Healthcare (US), Drдgerwerk AG (Germany), among others.
“Capnography accessories & disposables to register largest market share in 2022-2029.”
The largest share in capnography equipment consists of capnography accessories & disposables. Capnography accessories and disposables are also some of the necessary parts of the proper working of capnography equipment. These include disposable sampling lines, filters, and connectors, which are very necessary to maintain hygiene levels and prevent cross-contamination. Calibration gases are also needed to ensure the accuracy of measurements of capnography. Other devices would include power cords, wall mounts, and carrying cases that increase the convenience and portability of capnography devices.
“Hospitals segment held the largest share of capnography equipment market in 2023, by End-user.”
Based on the end-user, the capnography equipment market is segmented into hospitals. ambulatory surgery centers & home care and other end users. In the year 2023, the global capnography equipment market was dominated by hospitals. The use of capnography equipment is extremely prevalent in critical care areas, such as ICUs, operating rooms, emergency departments, and respiratory care units of hospitals. Such hospitals form the biggest market in the capnography equipment market because of this widespread usage. The growth of surgeries, critical care procedures, and respiratory illnesses has further led to a growing demand for capnography devices. In addition, the increased practice of monitoring patients for early respiratory complications detection along with the development of acute care has worked in favor of the integration of capnography in the clinical settings of hospitals.
'Asia Pacific to register highest growth rate in the market during the forecast period.'
The Asia-Pacific region is projected to exhibit the highest CAGR in the capnography equipment market. This growth is primarily driven by factors such as increasing healthcare expenditure, rising prevalence of respiratory diseases, growing geriatric population, and increasing awareness about the benefits of early detection and treatment of respiratory disorders. Additionally, the expanding healthcare infrastructure and increasing adoption of advanced medical technologies in countries like India and China are further contributing to the growth of the capnography equipment market in this region.
A number of drivers were responsible for the upswing, including:
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier1- 40%, Tier2- 30%, and Tier 3- 30%
- By Designation: C-level-- 55%, Director-level–27%, and Others–18%
- By Region: North America–35%, Europe-32%, Asia Pacific–25%, Latin America-6% , Middle East & Africa-2%
Research Coverage
Capnography equipment market is segmented by product, technology, application, end-user, and region. Factors determining market growth are driving forces, restrains, opportunities, and challenges, as well as those offering opportunities and challenges for stakeholders. Further examining the competitive landscape among the top players, the report does this. In doing so, it further segments the market into micro-markets for analyzing growth trends, prospects, and contribution to the overall market. It outlines the future revenue growth across the different market segments in five of the major regions.
Key Benefits of Buying the Report:
The report would be useful for new market entrants in the capnography equipment market as it gives detailed information about the market. This helps to get a good understanding of any investment opportunities. The report provides in-depth insight into key and smaller players which helps in doing strong risk assessment for investment decisions. The report segments the market precisely by both end-users and by regions to gain focused insights in specific market segments. Furthermore, it outlines the critical trends, challenges, growth drivers, and opportunities to facilitate strategic decision-making through well-rounded analysis.
The report provides the insights on the following pointers:
Analysis of the key drivers, restraints, opportunities, and challenges influencing the rise of the capnography equipment market The majority of the capnography equipment market is driven by the increase in chronic respiratory diseases such as asthma, COPD, and sleep apnea. There is an increasing demand for non-invasive monitoring solutions, especially in home care environments. Advancements in technology also involve miniaturization and wireless connectivity that enable smaller and user-friendly size capnography devices to be utilized.
Product Development/Innovation: The report showcases emerging technologies in the domain, ongoing R&D activities, and recent product and service launches in the market for capnography equipment.
Market Development: It has elaborated about the new product development and unexplored markets, latest developments, and investment in the capnography equipment market.
Market Diversification: Detailed insight into new product launches, unexplored markets, recent developments, and investments made in the capnography equipment market.
Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as Becton, Dickinson and company (US), Medtronic (US), Koninklijke Philips N.V.(Netherlands), GE Healthcare (US), Drдgerwerk AG (Germany), among others.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 SEGMENTS AND REGIONS CONSIDERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary sources
2.1.1.2 Objectives of secondary research
2.1.1.3 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Objectives of primary research
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Company revenue estimation approach
2.2.1.2 Customer-based market estimation
2.2.2 TOP-DOWN APPROACH
2.2.2.1 Primary interviews
2.3 DATA TRIANGULATION
2.4 MARKET SHARE ASSESSMENT
2.5 STUDY ASSUMPTIONS
2.6 GROWTH RATE ASSUMPTIONS/MARKET FORECASTING METHODOLOGY
2.7 RESEARCH LIMITATIONS
2.8 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CAPNOGRAPHY EQUIPMENT MARKET OVERVIEW
4.2 CAPNOGRAPHY EQUIPMENT MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
4.3 CAPNOGRAPHY EQUIPMENT MARKET, BY END USER AND COUNTRY,
2024 (USD MILLION)
4.4 GEOGRAPHIC SNAPSHOT OF CAPNOGRAPHY EQUIPMENT MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.1.1 DRIVERS
5.1.1.1 Increasing prevalence of respiratory diseases
5.1.1.2 Clinical benefits of capnography over pulse oximetry
5.1.1.3 Rising number of surgeries and target diseases requiring CO2 monitoring
5.1.2 RESTRAINTS
5.1.2.1 Complex regulatory framework for approval of capnography equipment
5.1.3 OPPORTUNITIES
5.1.3.1 Increased availability of clinical research evidence
5.1.3.2 Growth opportunities for healthcare industry in emerging economies
5.1.4 CHALLENGES
5.1.4.1 Lack of skilled technicians and specialized training for operating capnometers
5.2 INDUSTRY TRENDS
5.2.1 ADVANCEMENTS OF WEARABLE AND WIRELESS DEVICES
5.2.2 INTEGRATION WITH MULTIPARAMETER MONITORS
5.3 VALUE CHAIN ANALYSIS
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 BARGAINING POWER OF SUPPLIERS
5.4.3 BARGAINING POWER OF BUYERS
5.4.4 THREAT OF SUBSTITUTES
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 KEY STAKEHOLDERS & BUYING CRITERIA
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.5.2 KEY BUYING CRITERIA
5.6 PATENT ANALYSIS
5.7 TRADE DATA ANALYSIS
5.7.1 IMPORT DATA FOR HS CODE 9018
5.7.2 EXPORT DATA FOR HS CODE 9018
5.8 KEY CONFERENCES & EVENTS, 2024–2025
5.9 UNMET NEEDS AND KEY PAIN POINTS
5.10 ECOSYSTEM ANALYSIS
5.11 SUPPLY CHAIN ANALYSIS
5.11.1 PROMINENT COMPANIES
5.11.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.11.3 END USERS
5.12 IMPACT OF AI/GEN AI ON CAPNOGRAPHY EQUIPMENT MARKET
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.14 TECHNOLOGY ANALYSIS
5.14.1 KEY TECHNOLOGIES
5.14.1.1 Mainstream capnography
5.14.1.2 Side-stream capnography
5.14.1.3 Waveform capnography
5.14.2 COMPLEMENTARY TECHNOLOGIES
5.14.2.1 Pulse oximetry
5.14.2.2 Ventilators
5.14.3 ADJACENT TECHNOLOGIES
5.14.3.1 Microrotor technology
5.15 REGULATORY LANDSCAPE ANALYSIS
5.15.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.15.2 REGULATORY FRAMEWORK
5.15.2.1 North America
5.15.2.1.1 US
5.15.2.2 Europe
5.15.2.3 Asia Pacific
5.15.2.3.1 Japan
5.15.2.3.2 India
5.15.2.3.3 China
5.16 REIMBURSEMENT SCENARIO ANALYSIS
5.16.1 REIMBURSEMENT CODES FOR CAPNOGRAPHY PROCEDURES
5.16.2 REIMBURSEMENT LANDSCAPE FOR CAPNOGRAPHY EQUIPMENT, BY REGION
5.17 INVESTMENT & FUNDING SCENARIO
5.18 PRICING ANALYSIS
5.18.1 INDICATIVE SELLING PRICE OF CAPNOGRAPHY EQUIPMENT, BY REGION
5.18.2 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS,
BY KEY PLAYER, 2023
6 CAPNOGRAPHY EQUIPMENT MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 EQUIPMENT
6.2.1 MULTIPARAMETER CAPNOMETERS
6.2.1.1 Handheld multiparameter capnometers
6.2.1.1.1 Improved patient safety, portability, and inbuilt audible and visual alarm to aid adoption
6.2.1.2 Conventional multiparameter capnometers
6.2.1.2.1 Increasing number of complex surgeries involving anesthesia to support segment growth
6.2.2 STANDALONE CAPNOMETERS
6.2.2.1 Handheld standalone capnometers
6.2.2.1.1 Increasing number of emergency care visits and complex surgeries to propel segment growth
6.2.2.2 Conventional standalone capnometers
6.2.2.2.1 Easy portability and use in critical care settings to boost segment growth
6.3 SOFTWARE
6.3.1 BETTER CLINICAL DECISION-MAKING AND PATIENT MANAGEMENT TO FUEL MARKET GROWTH
6.4 CAPNOGRAPHY ACCESSORIES & DISPOSABLES
6.4.1 FAVORABLE REIMBURSEMENT SCENARIO TO SUPPORT MARKET GROWTH
7 CAPNOGRAPHY EQUIPMENT MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 MAINSTREAM CAPNOGRAPHY
7.2.1 HIGH ACCURACY, FAST RESPONSE TIME, AND IMPROVED SUITABILITY FOR NEONATES TO AID MARKET GROWTH
7.3 SIDE-STREAM CAPNOGRAPHY
7.3.1 RELIABLE MEASUREMENT OF END-TIDAL CO2 LEVELS TO PROPEL ADOPTION IN CLINICAL SETTINGS
7.4 MICROSTREAM CAPNOGRAPHY
7.4.1 LIMITATIONS IN BLACK-BODY INFRARED TECHNOLOGY TO LIMIT USAGE IN OPERATING ROOMS
8 CAPNOGRAPHY EQUIPMENT MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 CARDIAC CARE
8.2.1 INCREASING NUMBER OF CARDIOPULMONARY SURGERIES AND RISING PREFERENCE FOR MONITORING ETCO2 LEVELS TO DRIVE MARKET
8.3 TRAUMA & EMERGENCY CARE
8.3.1 INCREASING NUMBER OF ROAD ACCIDENTS TO SPUR MARKET GROWTH
8.4 RESPIRATORY MONITORING
8.4.1 RISING PREVALENCE OF TARGET RESPIRATORY CONDITIONS TO SUPPORT MARKET GROWTH
8.5 OTHER APPLICATIONS
9 CAPNOGRAPHY EQUIPMENT MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.2.1 FOCUS ON REDUCING AIRWAY-RELATED DEATHS IN ICU PATIENTS TO ACCELERATE MARKET GROWTH
9.3 AMBULATORY SURGERY CENTERS & HOME CARE SETTINGS
9.3.1 INCREASING NUMBER OF REIMBURSEMENT-APPROVED MEDICAL PROCEDURES UNDER ASC PAYMENT SYSTEM TO DRIVE MARKET
9.4 OTHER END USERS
10 CAPNOGRAPHY EQUIPMENT MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to dominate North American capnography equipment market during forecast period
10.2.3 CANADA
10.2.3.1 Rising prevalence of target respiratory diseases to support market growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Developed healthcare infrastructure and high government investments to spur market growth
10.3.3 UK
10.3.3.1 Increasing target patient population and rising healthcare expenditure to propel market growth
10.3.4 FRANCE
10.3.4.1 Growing awareness of capnography monitoring procedures and increasing number of trauma cases to augment market growth
10.3.5 ITALY
10.3.5.1 Rise in diabetes cases and high geriatric population to boost market growth
10.3.6 SPAIN
10.3.6.1 Increasing prevalence of lifestyle diseases to drive demand for capnography equipment
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Rising geriatric population and growing prevalence of obesity to augment market growth
10.4.3 CHINA
10.4.3.1 High target patient population and improved inpatient service availability to support market growth
10.4.4 INDIA
10.4.4.1 Favorable regulatory policies and high public healthcare expenditure to aid market growth
10.4.5 AUSTRALIA
10.4.5.1 Growing patient population and rising availability of grants to fuel market growth
10.4.6 SOUTH KOREA
10.4.6.1 Increased focus on R&D activities and high penetration of health insurance to propel market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Improved healthcare sector and increased private-public investments to drive market
10.5.3 MEXICO
10.5.3.1 Favorable trade environment and easy entry of foreign players to fuel market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Healthcare infrastructural developments and increased focus on patient safety to drive market
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CAPNOGRAPHY EQUIPMENT MARKET
11.3 REVENUE ANALYSIS, 2019–2023
11.4 MARKET SHARE ANALYSIS, 2023
11.4.1 RANKING OF KEY MARKET PLAYERS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Product footprint
11.5.5.3 Technology footprint
11.5.5.4 Application footprint
11.5.5.5 End-user footprint
11.5.5.6 Region footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES AND APPROVALS
11.9.2 DEALS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 BECTON, DICKINSON AND COMPANY
12.1.1.1 Business overview
12.1.1.2 Products/Services/Solutions offered
12.1.1.3 MnM view
12.1.1.3.1 Right to win
12.1.1.3.2 Strategic choices
12.1.1.3.3 Weaknesses and competitive threats
12.1.2 MEDTRONIC
12.1.2.1 Business overview
12.1.2.2 Products/Services/Solutions offered
12.1.2.3 Recent developments
12.1.2.3.1 Product approvals
12.1.2.3.2 Deals
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 KONINKLIJKE PHILIPS N.V.
12.1.3.1 Business overview
12.1.3.2 Products/Services/Solutions offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.4 MnM view
12.1.3.4.1 Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 GE HEALTHCARE
12.1.4.1 Business overview
12.1.4.2 Products/Services/Solutions offered
12.1.4.3 Recent developments
12.1.4.3.1 Deals
12.1.4.4 MnM view
12.1.4.4.1 Right to win
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 DRДGERWERK AG & CO. KGAA
12.1.5.1 Business overview
12.1.5.2 Products/Services/Solutions offered
12.1.5.3 MnM view
12.1.5.3.1 Right to win
12.1.5.3.2 Strategic choices
12.1.5.3.3 Weaknesses and competitive threats
12.1.6 NIHON KOHDEN CORPORATION
12.1.6.1 Business overview
12.1.6.2 Products/Services/Solutions offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.7 ZOLL MEDICAL CORPORATION
12.1.7.1 Business overview
12.1.7.2 Products/Services/Solutions offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.8 EDAN INSTRUMENTS, INC.
12.1.8.1 Business overview
12.1.8.2 Products/Services/Solutions offered
12.1.9 HAMILTON MEDICAL
12.1.9.1 Business overview
12.1.9.2 Products/Services/Solutions offered
12.1.9.3 Recent developments
12.1.9.3.1 Product launches
12.1.10 MASIMO
12.1.10.1 Business overview
12.1.10.2 Products/Services/Solutions offered
12.1.10.3 Recent developments
12.1.10.3.1 Product approvals
12.1.11 MINDRAY
12.1.11.1 Business overview
12.1.11.2 Products/Services/Solutions offered
12.1.11.3 Recent developments
12.1.11.3.1 Product launches
12.1.11.3.2 Deals
12.1.12 NONIN
12.1.12.1 Business overview
12.1.12.2 Products/Services/Solutions offered
12.1.12.3 Recent developments
12.1.12.3.1 Product launches
12.1.12.3.2 Deals
12.1.13 SCHILLER
12.1.13.1 Business overview
12.1.13.2 Products/Services/Solutions offered
12.1.14 AVANTE
12.1.14.1 Business overview
12.1.14.2 Products/Services/Solutions offered
12.1.15 ICU MEDICAL, INC.
12.1.15.1 Business overview
12.1.15.2 Products/Services/Solutions offered
12.1.15.3 Recent developments
12.1.15.3.1 Deals
12.2 OTHER PLAYERS
12.2.1 BIONICS CO., LTD.
12.2.2 BPL MEDICAL TECHNOLOGIES
12.2.3 BURTONS MEDICAL EQUIPMENT, LTD.
12.2.4 CRITICARE TECHNOLOGIES, INC.
12.2.5 DIAMEDICA (UK) LIMITED
12.2.6 INFINIUM MEDICAL
12.2.7 SPACELABS HEALTHCARE
12.2.8 NIDEK MEDICAL INDIA
12.2.9 RESMED
12.2.10 RECORDERS & MEDICARE SYSTEMS PVT. LTD.
12.2.11 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
12.2.12 SLE LTD.
12.2.13 ZOE MEDICAL
12.2.14 EMCO MEDITEK PVT. LTD.
12.2.15 MONARCH MEDITECH
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 SEGMENTS AND REGIONS CONSIDERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary sources
2.1.1.2 Objectives of secondary research
2.1.1.3 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Objectives of primary research
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Company revenue estimation approach
2.2.1.2 Customer-based market estimation
2.2.2 TOP-DOWN APPROACH
2.2.2.1 Primary interviews
2.3 DATA TRIANGULATION
2.4 MARKET SHARE ASSESSMENT
2.5 STUDY ASSUMPTIONS
2.6 GROWTH RATE ASSUMPTIONS/MARKET FORECASTING METHODOLOGY
2.7 RESEARCH LIMITATIONS
2.8 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CAPNOGRAPHY EQUIPMENT MARKET OVERVIEW
4.2 CAPNOGRAPHY EQUIPMENT MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
4.3 CAPNOGRAPHY EQUIPMENT MARKET, BY END USER AND COUNTRY,
2024 (USD MILLION)
4.4 GEOGRAPHIC SNAPSHOT OF CAPNOGRAPHY EQUIPMENT MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.1.1 DRIVERS
5.1.1.1 Increasing prevalence of respiratory diseases
5.1.1.2 Clinical benefits of capnography over pulse oximetry
5.1.1.3 Rising number of surgeries and target diseases requiring CO2 monitoring
5.1.2 RESTRAINTS
5.1.2.1 Complex regulatory framework for approval of capnography equipment
5.1.3 OPPORTUNITIES
5.1.3.1 Increased availability of clinical research evidence
5.1.3.2 Growth opportunities for healthcare industry in emerging economies
5.1.4 CHALLENGES
5.1.4.1 Lack of skilled technicians and specialized training for operating capnometers
5.2 INDUSTRY TRENDS
5.2.1 ADVANCEMENTS OF WEARABLE AND WIRELESS DEVICES
5.2.2 INTEGRATION WITH MULTIPARAMETER MONITORS
5.3 VALUE CHAIN ANALYSIS
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 BARGAINING POWER OF SUPPLIERS
5.4.3 BARGAINING POWER OF BUYERS
5.4.4 THREAT OF SUBSTITUTES
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 KEY STAKEHOLDERS & BUYING CRITERIA
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.5.2 KEY BUYING CRITERIA
5.6 PATENT ANALYSIS
5.7 TRADE DATA ANALYSIS
5.7.1 IMPORT DATA FOR HS CODE 9018
5.7.2 EXPORT DATA FOR HS CODE 9018
5.8 KEY CONFERENCES & EVENTS, 2024–2025
5.9 UNMET NEEDS AND KEY PAIN POINTS
5.10 ECOSYSTEM ANALYSIS
5.11 SUPPLY CHAIN ANALYSIS
5.11.1 PROMINENT COMPANIES
5.11.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.11.3 END USERS
5.12 IMPACT OF AI/GEN AI ON CAPNOGRAPHY EQUIPMENT MARKET
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.14 TECHNOLOGY ANALYSIS
5.14.1 KEY TECHNOLOGIES
5.14.1.1 Mainstream capnography
5.14.1.2 Side-stream capnography
5.14.1.3 Waveform capnography
5.14.2 COMPLEMENTARY TECHNOLOGIES
5.14.2.1 Pulse oximetry
5.14.2.2 Ventilators
5.14.3 ADJACENT TECHNOLOGIES
5.14.3.1 Microrotor technology
5.15 REGULATORY LANDSCAPE ANALYSIS
5.15.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.15.2 REGULATORY FRAMEWORK
5.15.2.1 North America
5.15.2.1.1 US
5.15.2.2 Europe
5.15.2.3 Asia Pacific
5.15.2.3.1 Japan
5.15.2.3.2 India
5.15.2.3.3 China
5.16 REIMBURSEMENT SCENARIO ANALYSIS
5.16.1 REIMBURSEMENT CODES FOR CAPNOGRAPHY PROCEDURES
5.16.2 REIMBURSEMENT LANDSCAPE FOR CAPNOGRAPHY EQUIPMENT, BY REGION
5.17 INVESTMENT & FUNDING SCENARIO
5.18 PRICING ANALYSIS
5.18.1 INDICATIVE SELLING PRICE OF CAPNOGRAPHY EQUIPMENT, BY REGION
5.18.2 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS,
BY KEY PLAYER, 2023
6 CAPNOGRAPHY EQUIPMENT MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 EQUIPMENT
6.2.1 MULTIPARAMETER CAPNOMETERS
6.2.1.1 Handheld multiparameter capnometers
6.2.1.1.1 Improved patient safety, portability, and inbuilt audible and visual alarm to aid adoption
6.2.1.2 Conventional multiparameter capnometers
6.2.1.2.1 Increasing number of complex surgeries involving anesthesia to support segment growth
6.2.2 STANDALONE CAPNOMETERS
6.2.2.1 Handheld standalone capnometers
6.2.2.1.1 Increasing number of emergency care visits and complex surgeries to propel segment growth
6.2.2.2 Conventional standalone capnometers
6.2.2.2.1 Easy portability and use in critical care settings to boost segment growth
6.3 SOFTWARE
6.3.1 BETTER CLINICAL DECISION-MAKING AND PATIENT MANAGEMENT TO FUEL MARKET GROWTH
6.4 CAPNOGRAPHY ACCESSORIES & DISPOSABLES
6.4.1 FAVORABLE REIMBURSEMENT SCENARIO TO SUPPORT MARKET GROWTH
7 CAPNOGRAPHY EQUIPMENT MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 MAINSTREAM CAPNOGRAPHY
7.2.1 HIGH ACCURACY, FAST RESPONSE TIME, AND IMPROVED SUITABILITY FOR NEONATES TO AID MARKET GROWTH
7.3 SIDE-STREAM CAPNOGRAPHY
7.3.1 RELIABLE MEASUREMENT OF END-TIDAL CO2 LEVELS TO PROPEL ADOPTION IN CLINICAL SETTINGS
7.4 MICROSTREAM CAPNOGRAPHY
7.4.1 LIMITATIONS IN BLACK-BODY INFRARED TECHNOLOGY TO LIMIT USAGE IN OPERATING ROOMS
8 CAPNOGRAPHY EQUIPMENT MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 CARDIAC CARE
8.2.1 INCREASING NUMBER OF CARDIOPULMONARY SURGERIES AND RISING PREFERENCE FOR MONITORING ETCO2 LEVELS TO DRIVE MARKET
8.3 TRAUMA & EMERGENCY CARE
8.3.1 INCREASING NUMBER OF ROAD ACCIDENTS TO SPUR MARKET GROWTH
8.4 RESPIRATORY MONITORING
8.4.1 RISING PREVALENCE OF TARGET RESPIRATORY CONDITIONS TO SUPPORT MARKET GROWTH
8.5 OTHER APPLICATIONS
9 CAPNOGRAPHY EQUIPMENT MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.2.1 FOCUS ON REDUCING AIRWAY-RELATED DEATHS IN ICU PATIENTS TO ACCELERATE MARKET GROWTH
9.3 AMBULATORY SURGERY CENTERS & HOME CARE SETTINGS
9.3.1 INCREASING NUMBER OF REIMBURSEMENT-APPROVED MEDICAL PROCEDURES UNDER ASC PAYMENT SYSTEM TO DRIVE MARKET
9.4 OTHER END USERS
10 CAPNOGRAPHY EQUIPMENT MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to dominate North American capnography equipment market during forecast period
10.2.3 CANADA
10.2.3.1 Rising prevalence of target respiratory diseases to support market growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Developed healthcare infrastructure and high government investments to spur market growth
10.3.3 UK
10.3.3.1 Increasing target patient population and rising healthcare expenditure to propel market growth
10.3.4 FRANCE
10.3.4.1 Growing awareness of capnography monitoring procedures and increasing number of trauma cases to augment market growth
10.3.5 ITALY
10.3.5.1 Rise in diabetes cases and high geriatric population to boost market growth
10.3.6 SPAIN
10.3.6.1 Increasing prevalence of lifestyle diseases to drive demand for capnography equipment
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Rising geriatric population and growing prevalence of obesity to augment market growth
10.4.3 CHINA
10.4.3.1 High target patient population and improved inpatient service availability to support market growth
10.4.4 INDIA
10.4.4.1 Favorable regulatory policies and high public healthcare expenditure to aid market growth
10.4.5 AUSTRALIA
10.4.5.1 Growing patient population and rising availability of grants to fuel market growth
10.4.6 SOUTH KOREA
10.4.6.1 Increased focus on R&D activities and high penetration of health insurance to propel market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Improved healthcare sector and increased private-public investments to drive market
10.5.3 MEXICO
10.5.3.1 Favorable trade environment and easy entry of foreign players to fuel market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Healthcare infrastructural developments and increased focus on patient safety to drive market
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CAPNOGRAPHY EQUIPMENT MARKET
11.3 REVENUE ANALYSIS, 2019–2023
11.4 MARKET SHARE ANALYSIS, 2023
11.4.1 RANKING OF KEY MARKET PLAYERS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Product footprint
11.5.5.3 Technology footprint
11.5.5.4 Application footprint
11.5.5.5 End-user footprint
11.5.5.6 Region footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES AND APPROVALS
11.9.2 DEALS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 BECTON, DICKINSON AND COMPANY
12.1.1.1 Business overview
12.1.1.2 Products/Services/Solutions offered
12.1.1.3 MnM view
12.1.1.3.1 Right to win
12.1.1.3.2 Strategic choices
12.1.1.3.3 Weaknesses and competitive threats
12.1.2 MEDTRONIC
12.1.2.1 Business overview
12.1.2.2 Products/Services/Solutions offered
12.1.2.3 Recent developments
12.1.2.3.1 Product approvals
12.1.2.3.2 Deals
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 KONINKLIJKE PHILIPS N.V.
12.1.3.1 Business overview
12.1.3.2 Products/Services/Solutions offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.4 MnM view
12.1.3.4.1 Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 GE HEALTHCARE
12.1.4.1 Business overview
12.1.4.2 Products/Services/Solutions offered
12.1.4.3 Recent developments
12.1.4.3.1 Deals
12.1.4.4 MnM view
12.1.4.4.1 Right to win
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 DRДGERWERK AG & CO. KGAA
12.1.5.1 Business overview
12.1.5.2 Products/Services/Solutions offered
12.1.5.3 MnM view
12.1.5.3.1 Right to win
12.1.5.3.2 Strategic choices
12.1.5.3.3 Weaknesses and competitive threats
12.1.6 NIHON KOHDEN CORPORATION
12.1.6.1 Business overview
12.1.6.2 Products/Services/Solutions offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.7 ZOLL MEDICAL CORPORATION
12.1.7.1 Business overview
12.1.7.2 Products/Services/Solutions offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.8 EDAN INSTRUMENTS, INC.
12.1.8.1 Business overview
12.1.8.2 Products/Services/Solutions offered
12.1.9 HAMILTON MEDICAL
12.1.9.1 Business overview
12.1.9.2 Products/Services/Solutions offered
12.1.9.3 Recent developments
12.1.9.3.1 Product launches
12.1.10 MASIMO
12.1.10.1 Business overview
12.1.10.2 Products/Services/Solutions offered
12.1.10.3 Recent developments
12.1.10.3.1 Product approvals
12.1.11 MINDRAY
12.1.11.1 Business overview
12.1.11.2 Products/Services/Solutions offered
12.1.11.3 Recent developments
12.1.11.3.1 Product launches
12.1.11.3.2 Deals
12.1.12 NONIN
12.1.12.1 Business overview
12.1.12.2 Products/Services/Solutions offered
12.1.12.3 Recent developments
12.1.12.3.1 Product launches
12.1.12.3.2 Deals
12.1.13 SCHILLER
12.1.13.1 Business overview
12.1.13.2 Products/Services/Solutions offered
12.1.14 AVANTE
12.1.14.1 Business overview
12.1.14.2 Products/Services/Solutions offered
12.1.15 ICU MEDICAL, INC.
12.1.15.1 Business overview
12.1.15.2 Products/Services/Solutions offered
12.1.15.3 Recent developments
12.1.15.3.1 Deals
12.2 OTHER PLAYERS
12.2.1 BIONICS CO., LTD.
12.2.2 BPL MEDICAL TECHNOLOGIES
12.2.3 BURTONS MEDICAL EQUIPMENT, LTD.
12.2.4 CRITICARE TECHNOLOGIES, INC.
12.2.5 DIAMEDICA (UK) LIMITED
12.2.6 INFINIUM MEDICAL
12.2.7 SPACELABS HEALTHCARE
12.2.8 NIDEK MEDICAL INDIA
12.2.9 RESMED
12.2.10 RECORDERS & MEDICARE SYSTEMS PVT. LTD.
12.2.11 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
12.2.12 SLE LTD.
12.2.13 ZOE MEDICAL
12.2.14 EMCO MEDITEK PVT. LTD.
12.2.15 MONARCH MEDITECH
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
